Stay updated on NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial
Sign up to get notified when there's something new on the NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial page.

Latest updates to the NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays a 403 Forbidden error, making the study record inaccessible. The prior study details have been removed and replaced with the standard error page layout.SummaryDifference16%

- Check36 days agoChange DetectedThe page now shows a new revision tag v3.6.6, indicating a platform update. No study data, eligibility criteria, or primary content were modified.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision label on the page updated from v3.6.4 to v3.6.5, signaling a new build of the page. No study details or patient-facing content are affected by this change.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, reflecting a minor update to the page's revision history and not altering the study details or content.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page’s revision tag was updated from v3.6.2 to v3.6.3, indicating a minor metadata update to the page. There are no changes to the study details or related information.SummaryDifference0.1%

- Check100 days agoChange DetectedThe page's revision indicator was updated from v3.6.0 to v3.6.2, signaling a new version of the page content. This update reflects a metadata revision rather than changes to the study data or description.SummaryDifference0.1%

Stay in the know with updates to NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial page.